Maryland State Retirement & Pension System’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Hold
16,871
0.01% 937
2025
Q4
$394K Buy
16,871
+332
+2% +$7.4K 0.01% 974
2025
Q3
$326K Sell
16,539
-17,157
-51% -$353K 0.01% 1065
2025
Q2
$731K Buy
33,696
+990
+3% +$23.4K 0.02% 739
2025
Q1
$793K Sell
32,706
-4,969
-13% -$112K 0.02% 661
2024
Q4
$786K Hold
37,675
0.02% 782
2024
Q3
$749K Sell
37,675
-1,448
-4% -$26.8K 0.02% 824
2024
Q2
$606K Sell
39,123
-1,139
-3% -$17.7K 0.01% 1008
2024
Q1
$635K Buy
40,262
+3,840
+11% +$57.9K 0.01% 957
2023
Q4
$612K Sell
36,422
-480
-1% -$6.56K 0.01% 990
2023
Q3
$431K Sell
36,902
-1,084
-3% -$14.5K 0.01% 1142
2023
Q2
$511K Sell
37,986
-571
-1% -$8.22K 0.01% 1078
2023
Q1
$639K Sell
38,557
-551
-1% -$9.09K 0.01% 865
2022
Q4
$727K Buy
39,108
+425
+1% +$6.54K 0.02% 736
2022
Q3
$496K Buy
+38,683
New +$458K 0.04% 330

Other funds holding CPRX

Maryland State Retirement & Pension System's CPRX Position: Q1 2026 in Review

Maryland State Retirement & Pension System held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 16,871 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #937.

Maryland State Retirement & Pension System first reported a position in CPRX in Q3 2022 and has held it in 15 quarters since. The position peaked at $793K in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Maryland State Retirement & Pension System held 16,871 shares of Catalyst Pharmaceutical worth $418K as of Q1 2026.
  • Maryland State Retirement & Pension System left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
  • Catalyst Pharmaceutical made up 0.01% of Maryland State Retirement & Pension System's portfolio in Q1 2026, its #937 holding.
  • Maryland State Retirement & Pension System first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 15 quarters since.
  • Maryland State Retirement & Pension System's Catalyst Pharmaceutical position peaked at $793K in Q1 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2026, filed 4 May 2026.